Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018
November 09, 2018 06:00 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO will be presenting at...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018
November 08, 2018 16:10 ET
|
Amphastar Pharmaceuticals, Inc.
Reports Net Revenues of $75.5 Million for the Three Months Ended September 30, 2018 RANCHO CUCAMONGA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)...
Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST
November 07, 2018 21:55 ET
|
Amphastar Pharmaceuticals, Inc.
Primatene® MIST fills unmet medical need as the only FDA approved over-the-counter asthma inhaler RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc.,...
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018
November 06, 2018 16:05 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its Third quarter of 2018 ended...
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018
November 02, 2018 16:05 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its Third quarter of 2018 ended...
Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018
August 29, 2018 16:05 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO will be presenting at...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2018
August 08, 2018 16:05 ET
|
Amphastar Pharmaceuticals, Inc.
Reports Net Revenues of $71.0 Million for the Three Months Ended June 30, 2018 RANCHO CUCAMONGA, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2018
August 03, 2018 06:00 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2018 ended June...
Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc.
July 09, 2018 06:00 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals...
Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP
June 19, 2018 06:00 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has granted approval of its...